文献速递结核与非结核分枝杆菌细菌感染、耐药与抗菌药物

中国杭州耐多药结核临床分离株吡嗪酰胺耐药的表型与基因型特征

Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China.
PubMed 文献 · Clin Microbiol Infect · 2017-12-26

该研究对291株耐多药结核分枝杆菌分离株进行pncA、rpsA和panD基因测序及吡嗪酰胺药敏试验,评估测序法检测吡嗪酰胺耐药的表现。结果显示pncA突变与耐药高度相关,联合检测三个基因可将灵敏度从90.1%提高至98.1%而特异性不变。

要点

  • pncA突变是耐多药结核吡嗪酰胺耐药的主要机制。
  • 联合检测pncA、rpsA和panD可提高耐药检出灵敏度至98.1%。
  • pncA野生型耐药株中rpsA/panD突变与吡嗪酰胺耐药相关。

核心结论

  • 吡嗪酰胺耐药主要与pncA突变相关。
  • 在pncA野生型的耐多药分离株中,rpsA和panD突变也与吡嗪酰胺耐药相关。
  • 检测pncA、rpsA和panD突变有助于判断吡嗪酰胺耐药。

研究设计与样本

  • 对291株耐多药结核临床分离株进行pncA、rpsA和panD基因测序及吡嗪酰胺药敏试验。

主要发现

  • 161株表型耐药株中145株(90.0%)存在pncA突变。
  • 16株(10.0%)无pncA突变,其中10株和3株分别有rpsA和panD突变。
  • 单用pncA测序检测耐药的灵敏度为90.1%(95%CI 84.4-94.2),特异性为92.3%(95%CI 86.3-96.3)。
  • 联合三个基因将灵敏度从90.1%(95%CI 84.4-94.2)提高至98.1%(95%CI 94.7-99.6)(p < 0.001),特异性不变。
  • 在120株吡嗪酰胺敏感和16株无pncA突变的耐药分离株中,rpsA/panD突变与吡嗪酰胺耐药相关。

关键数值与推荐

  • pncA测序灵敏度90.1%(95%CI 84.4-94.2),特异性92.3%(95%CI 86.3-96.3)。
  • pncA、rpsA和panD联合测序灵敏度98.1%(95%CI 94.7-99.6),特异性不变(p < 0.001)。

临床怎么用

  • 对耐多药结核分离株可考虑联合测序pncA、rpsA和panD以判断吡嗪酰胺耐药。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Pyrazinamide (PZA) is a crucial first-line tuberculosis (TB) drug recommended for both drug-susceptible and multidrug-resistant Mycobacterium tuberculosis. This study aimed to evaluate the performance of the sequencing method of pncA, rpsA and panD mutations in detecting PZA resistance in multidrug-resistant (MDR) TB isolates. METHODS: We sequenced the pncA, rpsA and panD genes and performed PZA susceptibility tests across 291 MDR-TB isolates to evaluate the performance of the sequencing method of these genes in detecting PZA resistance. RESULTS: Results showed that 145 (90.0%) of 161 PZA phenotypic resistant isolates had mutations in pncA. Among the 16 isolates (10.0%) which did not have mutations in pncA, ten and three isolates had mutations in rpsA and panD, respectively. The sequencing method for detecting mutations in pncA alone had 90.1% (95% confidence interval (CI), 84.4-94.2) sensitivity and 92.3% (95% CI, 86.3-96.3) specificity. The combination of all three genes increased the sensitivity from 90.1% (95% CI, 84.4-94.2) to 98.1% (95% CI, 94.7-99.6) (p < 0.001) while the specificity remained unchanged. In 120 PZA-susceptible and 16 PZA-resistant isolates without pncA mutations, rpsA/panD mutations were correlated with PZA resistance. CONCLUSIONS: PZA resistance was largely associated with mutations in pncA. Mutations in rpsA and panD were also associated with PZA resistance in MDR isolates expressing wild-type pncA. The detection of mutations in pncA, rpsA and panD can be useful for the determination of PZA resistance.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Liu W, Chen J, Shen Y, et al. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China. Clin Microbiol Infect. 2017. PMID: 29288021. doi:10.1016/j.cmi.2017.12.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。